Bonesupport Holding AB (publ) (STO:BONEX)

Market Cap	20.81B
Revenue (ttm)	997.85M
Net Income (ttm)	122.34M
Shares Out	65.86M
EPS (ttm)	1.84
PE Ratio	171.85
Forward PE	67.08
Dividend	n/a
Ex-Dividend Date	n/a

Volume	39,720
Average Volume	171,366
Open	317.40
Previous Close	316.00
Day's Range	300.40 - 317.40
52-Week Range	222.20 - 405.80
Beta	0.74
RSI	51.27
Earnings Date	Apr 24, 2025

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute t...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 139
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BONEX

Financial Performance

In 2024, Bonesupport Holding AB's revenue was 898.73 million, an increase of 52.05% compared to the previous year's 591.08 million. Earnings were 133.75 million, a decrease of -45.41%.